IMMUNOLOGIC RESPONSE OF CANCER PATIENTS MODIFIED BY IMMUNIZATION WITH TUMOR VACCINE = MODIFICATION DE LA REPONSE IMMUNOLOGIQUE DE MALADES ATTEINTS DE CANCER PAR IMMUNISATION AU MOYEN DE VACCIN TUMORALHUMPHREY LJ; BOEHM B; JEWELL WR et al.1972; ANN. SURG.; U.S.A.; DA. 1972; VOL. 176; NO 4; PP. 554-558; BIBL. 12 REF.Serial Issue

IMMUNOLOGICAL STIMULATION WITH MODIFIED CANCER CELLS = STIMULATION IMMUNOLOGIQUE PAR DES CELLULES CANCEREUSES MODIFIEESPRAGER MD.1973; BIOMEDICINE; FR.; DA. 1973; VOL. 18; NO 4; PP. 261-263; ABS. FR.; BIBL. 7REF.Serial Issue

STUDIES OF USE OF TUMOR VACCINE FOR THE CANCER PATIENT = ETUDES DE L'UTILISATION DE VACCINS TUMORAUX POUR LE MALADE ATTEINT DE CANCERHUMPHREY LJ; MURRAY DR; BOEHM OR et al.1973; BULL. SOC. INTERNATION. CHIR.; BELG.; DA. 1973; VOL. 32; NO 2; PP. 195-200; ABS. ALLEM. ESP. FR. ITAL. RUSSE; BIBL. 4REF.Serial Issue

PREMESSE IMMUNOLOGISCHE PER UN EVENTUALE TRATTAMENTO IMMUNOTERAPICO DEL CARCINOMA DELLA MAMMELLA = POSTULATS IMMUNOLOGIQUES POUR UNE EVENTUELLE IMMUNOTHERAPIE DU CANCER DU SEINRICCI M.1972; FOLIA ALLERGOL.; ITAL.; DA. 1972; VOL. 19; NO 4; PP. 273-295; BIBL. 3P.1/2Serial Issue

EFFECT OF SYNGENEIC TUMOR CELLS BOUND TO CONCANAVALIN A ON TUMOR GROWTH = EFFET DE CELLULES TUMORALES SYNGENIQUES LIEES A DE LA CONCANAVALINE A SUR LA CROISSANCE DES TUMEURSBRUGAROLAS A; TAKITA H; MOORE GE et al.1972; J. SURG. ONCOL.; U.S.A.; DA. 1972; VOL. 4; NO 2; PP. 123-130; BIBL. 7REF.Serial Issue

IMMUNOTHERAPY OF CANCER IN MAN. V. STUDIES OF PATIENTS WITH PRIMARY AND METASTATIC TUMORS OF THE LUNG = IMMUNOTHERAPIE DU CANCER CHEZ L'HOMME. V. ETUDE DE MALADES AYANT DES TUMEURS PRIMITIVES ET METASTATIQUES DES POUMONSHUMPHREY LJ; ABBOTT O; LOGAN W et al.1972; AMER. SURGEON; U.S.A.; DA. 1972; VOL. 38; NO 8; PP. 418-421; BIBL. 9 REF.Serial Issue

IMMUNOTHERAPY OF CANCER. PRESENT STATUS AND FUTURE POTENTIAL = L'IMMUNOTHERAPIE DU CANCER. ETAT ACTUEL ET POSSIBILITES FUTURESMORTON DL.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1647-1655; BIBL. 28 REF.Serial Issue

IMMUNOTHERAPY OF HUMAN LEUKEMIA = IMMUNOTHERAPIE DANS LA LEUCEMIE HUMAINEBAKER MA; TAUB RN.1972; MOUNT SINAI J. MED.; U.S.A.; DA. 1972; VOL. 39; NO 6; PP. 548-565; BIBL. 6P.Serial Issue

EFFECT OF ACTIVE IMMUNIZATION WITH IRRADIATED TUMOUR CELLS ON SPECIFIC SERUM INHIBITORS OF CELL-MEDIATED IMMUNITY IN PATIENTS WITH DISSEMINATED CANCER = EFFET DE L'IMMUNISATION ACTIVE AU MOYEN DE CELLULES TUMORALES IRRADIEES SUR LES INHIBITEURS SERIQUES SPECIFIQUES DE L'IMMUNITE A MEDIATION CELLULAIRE CHEZ DES MALADES ATTEINTS DE CANCER DISSEMINECURRIE GA.1973; BRIT. J. CANCER; G.B.; DA. 1973; VOL. 28; NO 1; PP. 25-35; BIBL. 8REF.Serial Issue

IMMUNOTHERAPY IN LEUKEMIA: EXPERIMENTAL AND CLINICAL APPROACHES = IMMUNOTHERAPIE DANS LA LEUCEMIE: TENTATIVES EXPERIMENTALES ET CLINIQUESMATHE G.1972; SER. HAEMATOL.; DANEM.; DA. 1972; VOL. 5; NO 5; PP. 66-86; BIBL. 4P.Serial Issue

INFLUENCE OF TUMOR ANTIGEN ON MAINTENANCE VERSUS DEPRESSION OF TUMOR-SPECIFIC IMMUNITY = INFLUENCE DE L'ANTIGENE TUMORAL SUR LE MAINTIEN OU LA DEPRESSION DE L'IMMUNITE TUMOROSPECIFIQUEVAAGE J.1973; CANCER RES.; U.S.A.; DA. 1973; VOL. 33; NO 3; PP. 493-503; BIBL. 13REF.Serial Issue

IMMUNIZATION OF MICE AGAINST TRANSPLANTABLE TUMOR = IMMUNISATION DE SOURIS CONTRE UNE TUMEUR TRANSPLANTABLEKAY ERM.1973; EXPERIENTIA; SUISSE; DA. 1973; VOL. 29; NO 6; PP. 710-711; ABS. ALLEM.; BIBL. 10REF.Serial Issue

IMMUNIZATION OF GUINEA PIGS AGAINST LEUKEMIA BY SCARIFICATION OF SKIN WITH LEUKEMIC CELL EXTRACTS = IMMUNISATION DE COBAYES CONTRE LA LEUCEMIE PAR SCARIFICATION CUTANEE AVEC DES EXTRAITS DE CELLULES LEUCEMIQUESGROSS L.1972; ACTA HAEMATOL.; SUISSE; DA. 1972; VOL. 47; NO 6; PP. 321-325; BIBL. 6REF.Serial Issue

IMMUNOTHERAPY COMBINED WITH PRIMARY RESECTION OF MURINE FIBROSARCOMA: CORRELATION OF IMMUNOLOGICAL STATUS OF THE HOST WITH PREVENTION OF METASTASES = IMMUNOTHERAPIE ASSOCIEE A LA RESECTION PRIMAIRE DE FIBROSARCOMES DE LA SOURIS: CORRELATION DE L'ETAT IMMUNOLOGIQUE DE L'HOTE AVEC LA PREVENTION DES METASTASESGODRICK EA; MICHAELSON JS; VANWIJCK R et al.1972; ANN. SURG.; U.S.A.; DA. 1972; VOL. 176; NO 4; PP. 544-553; BIBL. 21 REF.Serial Issue

IMMUNOTHERAPEUTIC TRIALS IN SARCOMA PATIENTS USING AUTOGENOUS TUMOR VACCINE = ESSAIS D'IMMUNOTHERAPIE CHEZ DES MALADES ATTEINTS D'UN SARCOME A L'AIDE D'UN VACCIN DE TUMEUR AUTOLOGUESOUTHAM CM.1972; FRONTIERS RADIAT. THERAP. ONCOL.; SWITZ.; DA. 1972; NO 7; PP. 199-212; BIBL. 14REF.Serial Issue

PRESERVATION OF CELLULAR ANTIGENICITY OF TUMOR CELLS BY THE USE OF FORMALIN FIXATION = PRESERVATION DE L'ANTIGENICITE CELLULAIRE DES CELLULES TUMORALES PAR L'UTILISATION DE LA FIXATION PAR LE FORMOLDRAKE WP; UNGARO PC; MARDINEY MR JR et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 5; PP. 1042-1044; BIBL. 12REF.Serial Issue

USE OF BACILLUS CALMETTE-GUERIN AS ADJUVANT IN HUMAN CELL VACCINES = UTILISATION DU BACILLE DE CALMETTE-GUERIN COMME ADJUVANT DANS LES VACCINS CELLULAIRES HUMAINSSOKAL JE; AUNGST CW; TIN HAN et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 7; PP. 1584-1589; BIBL. 14 REF.Serial Issue

INCREASED INCIDENCE OF LUNG METASTASES FOLLOWING TREATMENT OF RATS BEARING HEPATOMAS WITH IRRADIATED TUMOUR CELLS AND THE BENEFICIAL EFFECT OF CORYNEBACTERIUM PARVUM IN THIS SYSTEM = FREQUENCE ACCRUE DE METASTASES PULMONAIRES APRES TRAITEMENT DE RATS PORTEURS D'HEPATOME PAR CELLULES TUMORALES IRRADIEES, ET EFFET BENEFIQUE DE CORYNEBACTERIUM PARVUM DANS CE SYSTEMEPROCTOR J; RUDENSTAM CM; ALEXANDER P et al.1973; BIOMEDICINE; FR.; DA. 1973; VOL. 19; NO 6; PP. 248-252; ABS. FR.; BIBL. 12REF.Serial Issue

IMMUNOLOGY OF HUMAN MALIGNANT MELANOMA = IMMUNOLOGIE DU MELANOME MALIN HUMAINLEWIS MG.1972; SER. HAEMATOL.; DANEM.; DA. 1972; VOL. 5; NO 5; PP. 44-65; BIBL. 4P.Serial Issue

COLON CARCINOMA AND IMMUNOLOGIC PHENOMENA = CANCER DU COLON ET PHENOMENE IMMUNOLOGIQUEGRIFFEN WO JR; MEEKER WR.1972; SURG. CLIN. N. AMER.; U.S.A.; DA. 1972; VOL. 52; NO 4; PP. 839-846; BIBL. 1P.Serial Issue

HORIZONS IN TUMOR IMMUNOLOGY = PERSPECTIVES DANS L'IMMUNOLOGIE DES TUMEURSMORTON DL.1973; SURGERY; U.S.A.; DA. 1973; VOL. 74; NO 1; PP. 69-79; BIBL. 1P.Serial Issue

IMMUNOTHERAPY OF MALIGNANT MELANOMA. A CLINICAL TRIAL = IMMUNOTHERAPIE DU MELANOME MALIN. UNE EXPERIMENTATION CLINIQUEMCCARTHY WH; COTTON G; CARLON A et al.1973; CANCER; U.S.A.; DA. 1973; VOL. 32; NO 1; PP. 97-103; BIBL. 1P.Serial Issue

ESSAIS D'IMMUNOTHERAPIE ACTIVE DANS LA LEUCEMIE AIGUE LYMPHOIDE. INFLUENCE DE DIVERS FACTEURS SUR LES RESULTATS. ETUDE DE 100 MALADESMATHE G; POUILLART P; SCHWARZENBERG L et al.1973; NOUV. PRESSE MED.; FR.; DA. 1973; VOL. 2; NO 9; PP. 557-562; BIBL. 20REF.Serial Issue

POSSIBILITY OF IN VITRO ALTERATIONS IN CULTURES OF MAMMARY CARCINOMA CELLS, AND ALTERED IMMUNOLOGICAL RESPONSE IN THE RAT: ACQUIRED CAPACITY TO REJECT INJECTIONS OF MAMMARY CARCINOMA CELLS AND IMPLANTS OF MAMMARY CARCINOMA = POSSIBILITE D'ALTERATIONS IN VITRO DANS DES CULTURES DE CELLULES DE TUMEUR MAMMAIRE ET REPONSE IMMUNE ALTEREE CHEZ LE RAT: CAPACITE ACQUISE DE REJETER DES INJECTIONS DE CELLULES DE TUMEUR MAMMAIRE ET DES IMPLANTS DE TUMEUR MAMMAIRESTONE D; ZACARIAN SA; PICKERING K et al.1972; BRIT. J. CANCER; G.B.; DA. 1972; VOL. 26; NO 4; PP. 315-320; BIBL. 6REF.Serial Issue

RESULTATS DE 5 CAS D'IMMUNOTHERAPIE ACTIVE DU CANCERSERROU B; SOLASSOL C; MEISS L et al.1972; J. MED. MONTPELLIER,; FR.; DA. 1972; VOL. 7; NO 8; PP. 391-396; BIBL. 17REF.Serial Issue